Top

Strahlentherapie und Onkologie

Published in:

01-12-2012 | Original article

Radiation therapy for primary carcinoma of the eyelid: tumor control and visual function

Authors: M. Hata, MD, I. Koike, J. Maegawa, A. Kaneko, K. Odagiri, T. Kasuya, Y. Minagawa, H. Kaizu, Y. Mukai, T. Inoue

Published in: Strahlentherapie und Onkologie | Issue 12/2012

Abstract

Background and purpose

Surgical excision remains the standard and most reliable curative treatment for eyelid carcinoma, but frequently causes functional and cosmetic impairment of the eyelid. We therefore investigated the efficacy and safety of radiation therapy in eyelid carcinoma.

Patients and methods

Twenty-three patients with primary carcinoma of the eyelid underwent radiation therapy. Sebaceous carcinoma was histologically confirmed in 16 patients, squamous cell carcinoma in 6, and basal cell carcinoma in 1. A total dose of 50–66.6 Gy (median, 60 Gy) was delivered to tumor sites in 18–37 fractions (median, 30 fractions).

Results

All but 3 of the 23 patients had survived at a median follow-up period of 49 months. The overall survival and local progression-free rates were 87% and 93% at 2 years, and 80% and 93% at 5 years, respectively. Although radiation-induced cataracts developed in 3 patients, visual acuity in the other patients was relatively well preserved. There were no other therapy-related toxicities of grade 3 or greater.

Conclusion

Radiation therapy is safe and effective for patients with primary carcinoma of the eyelid. It appears to contribute to prolonged survival as a result of good tumor control, and it also facilitates functional and cosmetic preservation of the eyelid.

Berenbom A, Davila RM, Lin HS et al (2007) Treatment outcomes for primary intraocular lymphoma: implications for external beam radiotherapy. Eye 21:1198–1201PubMedCrossRef

Cook BE Jr, Bartley GB (1999) Epidemiologic characteristics and clinical course of patients with malignant eyelid tumors in an incidence cohort in Olmsted Country, Minnesota. Ophthalmology 106:746–750PubMedCrossRef

Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341–1346PubMedCrossRef

Ejima Y, Sasaki R, Okamoto Y et al (2006) Ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy. Radiother Oncol 78:6–9PubMedCrossRef

Fitzpatrick PJ, Thompson GA, Easterbrook WM et al (1984) Basal and squamous cell carcinoma of the eyelids and their treatment by radiotherapy. Int J Radiat Oncol Biol Phys 10:449–454PubMedCrossRef

Hata M, Koike I, Omura M et al (2012) Noninvasive and curative radiation therapy for sebaceous carcinoma of the eyelid. Int J Radiat Oncol Biol Phys 82:605–611PubMedCrossRef

Hendley RL, Rieser JC, Cavanagh HD et al (1979) Primary radiation therapy for meibomian gland carcinoma. Am J Ophthalmol 87:206–209PubMed

Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481CrossRef

Kniestedt C, Stamper RL (2003) Visual acuity and its measurement. Ophthalmol Clin North Am 16:155–170PubMedCrossRef

10.

Kuhnt T, Klockenbrink U, Knipping S et al (2011) Adjuvant low single dose cisplatin-based concurrent radiochemotherapy of oral cavity and oropharynx carcinoma: impact of extracapsular nodal spread on distant metastases. Strahlenther Onkol 187:292–299PubMedCrossRef

11.

Kumar R (2010) Clinicopathologic study of malignant eyelid tumors. Clin Exp Optom 93:224–227PubMedCrossRef

12.

Lentrodt J (1977) Principles of the surgical therapy of eyelid tumours. J Maxillofac Surg 5:93–107PubMedCrossRef

13.

Lin HY, Cheng CY, Hsu WM et al (2006) Incidence of eyelid cancers in Taiwan: a 21-year review. Ophthalmology 113:2101–2107PubMedCrossRef

14.

Moesen I, Duncan M, Cates C et al (2011) Nitrous oxide cryotherapy for primary periocular basal cell carcinoma: outcome at 5 years follow-up. Br J Ophthalmol 95:1679–1681PubMedCrossRef

15.

Mombaerts I, Gillis A (2010) The tunneled forehead flap in medial canthal and eyelid reconstruction. Dermatol Surg 36:1118–1125PubMedCrossRef

16.

Nunery WR, Welsh MG, McCord CD Jr (1983) Recurrence of sebaceous carcinoma of the eyelid after radiation therapy. Am J Ophthalmol 96:10–15PubMed

17.

Pardo FS, Wang CC, Albert D et al (1989) Sebaceous carcinoma of the ocular adnexa: radiotherapeutic management. Int J Radiat Oncol Biol Phys 17:643–647PubMedCrossRef

18.

Petsuksiri J, Frank SJ, Garden AS et al (2008) Outcomes after radiotherapy for squamous cell carcinoma of the eyelid. Cancer 112:111–118PubMedCrossRef

19.

Rades D, Meyners T, Kazic N et al (2011) Comparison of radiochemotherapy alone to surgery plus radio(chemo)therapy for non-metastatic stage III/IV squamous cell carcinoma of the head and neck. A matched-pair analysis. Strahlenther Onkol 187:541–547PubMedCrossRef

20.

Rades D, Seibold ND, Gebhard MP et al (2011) Prognostic factors (including HPV status) for irradiation of locally advanced squamous cell carcinoma of the head and neck (SCCHN). Strahlenther Onkol 187:626–632PubMedCrossRef

21.

Reading VM, Weale RA (1993) Self-administered automatic sight-testing. A feasibility study. Doc Ophthalmol 83:43–54PubMedCrossRef

22.

Rosa J, Casal D, Moniz P (2010) Upper eyelid reconstruction with a horizontal V-Y myotarsocutaneous advancement flap. J Plast Reconstr Aesthet Surg 63:2013–2017PubMedCrossRef

23.

Russell HC, Chadha V, Lockington D et al (2010) Topical mitomycin C chemotherapy in the management of ocular surface neoplasia: a 10-year review of treatment outcomes and complications. Br J Ophthalmol 94:1316–1321PubMedCrossRef

24.

Swanson MW, Cloud G (1991) A retrospective analysis of primary eye cancer at the University of Alabama 1958–1988. Part 2: eyelid tumors. J Am Optom Assoc 62:820–823PubMed

25.

Takamura H, Yamashita H (2005) Clinicopathological analysis of malignant eyelid tumor cases at Yamagata University Hospital: statistical comparison of tumor incidence in Japan and in other countries. Jpn J Ophthalmol 49:349–354PubMedCrossRef

26.

Wang JK, Liao SL, Jou JR et al (2003) Malignant eyelid tumours in Taiwan. Eye 17:216–220PubMedCrossRef

27.

Wolff HA, Bosch J, Jung K et al (2010) High-grade acute organ toxicity as positive prognostic factor in primary radio(chemo)therapy for locally advanced, inoperable head and neck cancer. Strahlenther Onkol 186:262–268PubMedCrossRef

Title: Radiation therapy for primary carcinoma of the eyelid: tumor control and visual function
Authors: M. Hata, MD
I. Koike
J. Maegawa
A. Kaneko
K. Odagiri
T. Kasuya
Y. Minagawa
H. Kaizu
Y. Mukai
T. Inoue
Publication date: 01-12-2012
Publisher: Springer-Verlag
Published in: Strahlentherapie und Onkologie / Issue 12/2012
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI: https://doi.org/10.1007/s00066-012-0145-9

At a glance: The STEP trials

Springer Medicine

Radiation therapy for primary carcinoma of the eyelid: tumor control and visual function

Abstract

Background and purpose

Patients and methods

Results

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Background and purpose

Patients and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 12/2012

Radikale Prostatektomie versus Zuwarten beim lokalisierten Prostatakarzinom

Mitteilungen

Prognostic factors and a survival score for patients with metastatic spinal cord compression from colorectal cancer

When are breast cancer patients old enough for the quitclaim of local control?

Plasminogen activator inhibitor-1 (PAI-1) expression in relation to hypoxia and oncoproteins in clinical cervical tumors

Benign painful shoulder syndrome